FindTrial
Sign In

Effects of Chinese Medicine Acupoint Application on Chemotherapy-related Gastrointestinal Side Effects in Children with Malignant Tumor

Effects of Chinese Medicine Acupoint Application on Chemotherapy-related Gastrointestinal Side Effects in Children with Malignant Tumor

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003371
Enrollment
Unknown
Registered
2020-06-05
Start date
2020-06-08
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

control group:Placebo Acupoint Application
experimental group:Chinese Medicine Acupoint Application

Sponsors

Xinhua Hospital Affliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Diagnosed as NHL and receiving intensified treatment; diagnosed as high-risk neuroblastoma; 2. Expected to complete the chemotherapy according to regimen; 3. Age from 1-12 years old without gender limitation; 4. The legal guardians agree to receive the Chinese Medicine Acupoint Application and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Gastrointestinal symptoms caused other than chemotherapy; 2. Skin infection or damage in location of Chinese Medicine Acupoint Application; 3. Be allergic to drugs used in Chinese Medicine Acupoint Application.

Design outcomes

Primary

MeasureTime frame
TCM syndrome score;Gastrointestinal symptoms grading according to CTCAE v3.0;—

Countries

China

Contacts

Public ContactLiping Qin

Xinhua Hospital Affliated to Shanghai Jiaotong University School of Medicine

bbb___1243@126.com+86 18717761006

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026